ABBV-295
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABBV-295, covering 2025-12-18 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity. [Phase 1]